Reuters logo
BRIEF-GSK receives FDA approval for expanded indication for flulaval quadrivalent (influenza vaccine) for infants 6 months and older
2016年11月21日 / 下午1点37分 / 10 个月前

BRIEF-GSK receives FDA approval for expanded indication for flulaval quadrivalent (influenza vaccine) for infants 6 months and older

Nov 21 (Reuters) - Glaxosmithkline Plc :

* GSK receives FDA approval for expanded indication for flulaval quadrivalent (influenza vaccine) for infants 6 months and older Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below